Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.
about
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageCytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patientsComplementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.Clinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis.Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinomaGlycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathwaySerum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B.Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.(Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts.The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis.Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.Progress in non-invasive detection of liver fibrosis.UEG Week 2015 Poster Presentations
P2860
Q26773289-4B413364-1138-4234-B79C-7683883EFB2EQ33637279-E105073B-B300-4302-9F4E-164DEC57E74BQ33895173-CE434232-21CC-459E-BB0F-18F740197D0DQ35653461-6B3BA03A-97E5-477D-93CC-08E73F6D98C0Q35744895-61BA342C-A8A0-4331-ACDD-44C1A0B7ADE9Q36975008-440F2CA2-540A-43D8-8636-8B28CD409E67Q40062007-6FB877A4-E545-4142-82C5-7F29EAEFA095Q40084913-454621D2-2FA9-42F5-8FCF-1FEE55720CD0Q41528078-232178C1-4A8F-48EB-BEBE-D0A397567EF5Q42223298-3D71F205-3A8C-4012-9316-3DC83C26499CQ42247927-B213C7E8-E0B3-4FF7-8038-9FB110B055EBQ42249715-1A969033-B6C8-4C5C-8524-CAF999CC8B6EQ55421930-878B921A-9881-401F-9669-184455D8FF7EQ56934656-907AC4F2-8F47-418D-8CD9-AF5A0F5A8E9A
P2860
Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Elevated serum CK18 levels in ...... ed fibrosis but not steatosis.
@en
type
label
Elevated serum CK18 levels in ...... ed fibrosis but not steatosis.
@en
prefLabel
Elevated serum CK18 levels in ...... ed fibrosis but not steatosis.
@en
P2093
P2860
P1476
Elevated serum CK18 levels in ...... ced fibrosis but not steatosis
@en
P2093
A B Jazwinski
A J Thompson
H L Tillmann
P2860
P304
P356
10.1111/J.1365-2893.2011.01546.X
P50
P577
2011-11-24T00:00:00Z